Efficacy and safety of HERG channel agonists for treatment of Long QT Syndrome type 8

1 September 2024 (16:00 - 16:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Deni Kukavica

ICS Maugeri - IRCCS Pavia, Pavia (Italy)

8 More presentations in this session

Presentation thumbnail

Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.

Doctor Q. Majid (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Advancing cardiac 3D organoid-on-chip: integrating iPSC-derived MELAS syndrome models to study electromechanical synchronicity and cardiac memory using contactless technology

Associate Professor M. Miragoli (Parma, IT)

Abstract Slides Video

Presentation thumbnail

Investigating the role of WT1 in Brugada syndrome pathophysiology

Ms M. Marsman (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Computational modeling of cardiac electrophysiology applied to a swine model of Long QT Syndrome

Doctor A. Trancuccio (Pavia, IT)

Abstract Slides Video

Presentation thumbnail

Indoxyl sulfate deteriorates cardiac electrophysiological function and increases the likelihood of arrhythmias in human ventricular myocardial cells

Mr O. Pfeuffer (Regensburg, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Novel insights into arrhythmias

The Event

Event poster

ESC Congress 2024

1 September 2024 16:00 CET

You may be interested in

Congress Presentation

Computational modeling of cardiac electrophysiology applied to a swine model of Long QT Syndrome

Congress Presentation

Novel personalised therapies of long QT and short QT syndromes

Congress Session

Molecular and cellular drivers of arrhythmia

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources